-
Innovation Ranking
NewInnovation Ranking – AIM ImmunoTech Inc
AIM ImmunoTech Inc (AIM ImmunoTech), formerly Hemispherx Biopharma Inc, is an immuno- pharma company. The company focuses on the research and development of therapeutics for the treatment of multiple types of cancers, viruses and immune-deficiency disorders. Its flagship products include Ampligen (rintatolimod) sterile solution which is indicated for the treatment of patients with chronic fatigue syndrome; and Alferon N Injection used for the treatment of refractory or recurrent external condylomata acuminate. The company’s pipeline products are intended to treat various...
-
Sector Analysis
NewSix Nations (Rugby Championship), 2024 – Event Analysis
Six Nations Rugby Championship 2024 Event Analysis Report Overview The annual sponsorship revenue for the Six Nations Rugby Championship 2024 is estimated to be $26.33 million. A Six Nations documentary released on Netflix before the tournament was aimed to increase the viewership for this year's tournament. The opening game of the Six Nations brought in an average audience of more than 6 million for host broadcaster France Televisions. The Six Nations Rugby Championship 2024 event analysis report identifies the sponsorship...
-
Sector Analysis
NewVietnam Telecom Operators Country Intelligence Report
Vietnam Telecom Operators Country Intelligence Overview The total telecom service revenue in Vietnam reached $6.4 billion in 2023. The market size growth has been estimated to incline at a CAGR of more than 4% during 2023-2028. This growth will be supported by a spike in mobile data and fixed broadband service segments. Also, the National Digital Transformation Program - 2025 aimed at speeding up digital transformation by changing business strategies and providing incentives to encourage enterprises, government administration, and manufacturing...
-
Product Insights
NewLikelihood of Approval Analysis for Acquired (Autoimmune) Hemolytic Anemia
Overview How likely is it that the drugs in Acquired (Autoimmune) Hemolytic Anemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acquired (Autoimmune) Hemolytic Anemia Overview Acquired autoimmune hemolytic anemia (AIHA)...
-
Product Insights
NewLikelihood of Approval Analysis for Bleeding And Clotting Disorders
Overview How likely is it that the drugs in Bleeding And Clotting Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bleeding And Clotting Disorders Overview Bleeding and clotting disorders are...
-
Product Insights
NewLikelihood of Approval Analysis for Metastatic Adenocarcinoma of The Pancreas
Overview How likely is it that the drugs in Metastatic Adenocarcinoma of The Pancreas will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Adenocarcinoma of The Pancreas Overview Metastatic adenocarcinoma is...
-
Product Insights
NewLikelihood of Approval Analysis for Myelofibrosis
Overview How likely is it that the drugs in Myelofibrosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Myelofibrosis Overview Myelofibrosis is a rare bone marrow disorder where abnormal cells cause...
-
Product Insights
NewLikelihood of Approval Analysis for Recurrent Glioblastoma Multiforme (GBM)
Overview How likely is it that the drugs in Recurrent Glioblastoma Multiforme (GBM) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Recurrent Glioblastoma Multiforme (GBM) Overview Recurrent glioblastoma multiforme (GBM) refers...
-
Product Insights
NewLikelihood of Approval Analysis for Stem Cell Transplantation
Overview How likely is it that the drugs in Stem Cell Transplantation will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Stem Cell Transplantation Overview Stem cell transplantation, also known as hematopoietic...
-
Product Insights
NewLikelihood of Approval Analysis for Pulmonary Tuberculosis
Overview How likely is it that the drugs in Pulmonary Tuberculosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pulmonary Tuberculosis Overview Pulmonary tuberculosis (TB) is an infectious respiratory disease caused...